T1	Procedure 21 38	catheter ablation
T2	Procedure 30 38;9 17	ablation surgical
*	OR T1 T2
T3	Condition 43 62	atrial fibrillation
T4	Scope 9 38	surgical or catheter ablation
R1	AND Arg1:T4 Arg2:T3	
T5	Procedure 73 88	cardiac surgery
T6	Temporal 0 8	Previous
T7	Temporal 64 72	Previous
R2	Has_temporal Arg1:T4 Arg2:T6	
R3	Has_temporal Arg1:T5 Arg2:T7	
T8	Procedure 100 104	CABG
T9	Temporal 106 141	within the past 6 months (180 days)
R4	Subsumes Arg1:T5 Arg2:T8	
R5	Has_temporal Arg1:T5 Arg2:T9	
T10	Procedure 143 159;169 191	Valvular cardiac percutaneous procedure
T11	Procedure 143 168;182 191	Valvular cardiac surgical procedure
*	OR T10 T11
T12	Procedure 199 213	ventriculotomy
T13	Procedure 215 224	atriotomy
T14	Procedure 230 242	valve repair
T15	Procedure 230 235;246 257	valve replacement
T16	Device 276 292	prosthetic valve
*	OR T12 T13 T15 T14 T16
T17	Scope 199 292	ventriculotomy, atriotomy, and valve repair or replacement and presence of a prosthetic valve
T18	Scope 143 191	Valvular cardiac surgical/percutaneous procedure
R6	Subsumes Arg1:T18 Arg2:T17	
T19	Device 299 315	carotid stenting
T20	Procedure 319 333	endarterectomy
*	OR T19 T20
T21	Condition 346 357	LA thrombus
T22	Procedure 361 368	imaging
R7	AND Arg1:T22 Arg2:T21	
T23	Measurement 370 377	LA size
T24	Value 378 385	> 50 mm
T25	Qualifier 387 413	parasternal long axis view
R8	Has_qualifier Arg1:T23 Arg2:T25	
R9	Has_value Arg1:T23 Arg2:T24	
T26	Measurement 416 420	LVEF
T27	Value 421 426	< 40%
R10	Has_value Arg1:T26 Arg2:T27	
T28	Condition 428 444	Contraindication
T29	Drug 448 463	anticoagulation
R11	AND Arg1:T28 Arg2:T29	
T30	Drug 465 472	heparin
T31	Drug 476 484	warfarin
*	OR T30 T31
T32	Scope 465 484	heparin or warfarin
T33	Scope 428 463	Contraindication to anticoagulation
R12	Subsumes Arg1:T33 Arg2:T32	
T34	Observation 487 494	History
T35	Condition 498 512	blood clotting
T36	Condition 516 538	bleeding abnormalities
*	OR T35 T36
T37	Scope 498 538	blood clotting or bleeding abnormalities
R13	Has_temporal Arg1:T37 Arg2:T34	
T38	Condition 544 546	MI
T39	Procedure 540 543	PCI
T40	Temporal 547 571	within the past 2 months
T41	Temporal 547 562;573 580	within the past 60 days
*	OR T41 T40
T42	Scope 547 581	within the past 2 months (60 days)
T43	Scope 540 546	PCI/MI
R14	Subsumes Arg1:T43 Arg2:T42	
T44	Condition 594 614	thromboembolic event
T45	Condition 626 629	TIA
R15	Subsumes Arg1:T44 Arg2:T45	
T46	Temporal 631 656	within the past 12 months
T47	Temporal 631 646;658 666	within the past 365 days
*	OR T46 T47
T48	Scope 631 667	within the past 12 months (365 days)
T49	Scope 594 630	thromboembolic event (including TIA)
R16	Has_scope Arg1:T49 Arg2:T48	
T50	Condition 669 692	Rheumatic Heart Disease
T51	Qualifier 694 706	Uncontrolled
T52	Condition 707 720	heart failure
T53	Measurement 724 743	NYHA function class
T54	Value 744 747	III
T55	Value 751 753	IV
*	OR T54 T55
T56	Scope 744 753	III or IV
R17	Has_scope Arg1:T53 Arg2:T56	
R18	Has_qualifier Arg1:T52 Arg2:T51	
T57	Scope 724 753	NYHA function class III or IV
R19	Has_scope Arg1:T52 Arg2:T57	
T58	Condition 762 782	mitral regurgitation
T59	Qualifier 755 761	Severe
R20	Has_qualifier Arg1:T58 Arg2:T59	
T62	Measurement 784 802	Regurgitant volume
T63	Value 803 815	= 60 mL/beat
R21	Has_value Arg1:T62 Arg2:T63	
T60	Measurement 817 837	Regurgitant fraction
T61	Value 838 843	= 50%
R22	Has_value Arg1:T60 Arg2:T61	
T64	Measurement 852 886	Effective regurgitant orifice area
T65	Value 887 896	= 0.40cm2
R23	Has_value Arg1:T64 Arg2:T65	
*	OR T60 T64 T62
T66	Scope 784 896	Regurgitant volume = 60 mL/beat, Regurgitant fraction = 50%, and/or Effective regurgitant orifice area = 0.40cm2
T67	Scope 755 782	Severe mitral regurgitation
R24	Has_scope Arg1:T67 Arg2:T66	
T68	Procedure 908 931	cardiac transplantation
T69	Procedure 941 956	cardiac surgery
T70	Temporal 957 982	within the next 12 months
T71	Temporal 957 972;984 992	within the next 365 days
R25	Subsumes Arg1:T70 Arg2:T71	
*	OR T68 T69
T72	Scope 908 956	cardiac transplantation or other cardiac surgery
R26	Has_temporal Arg1:T72 Arg2:T70	
T73	Condition 995 1010	Unstable angina
T74	Condition 1012 1025	Acute illness
T75	Condition 1036 1054	systemic infection
T76	Qualifier 1029 1035	active
T77	Condition 1058 1064	sepsis
T78	Condition 1066 1068	AF
T79	Condition 1082 1103	electrolyte imbalance
T80	Qualifier 1069 1078	secondary
R27	AND Arg1:T80 Arg2:T79	
R28	Has_qualifier Arg1:T78 Arg2:T80	
T81	Condition 1105 1120	thyroid disease
T82	Condition 1139 1156	non-cardiac cause
T83	Qualifier 1125 1135	reversible
R29	Has_qualifier Arg1:T82 Arg2:T83	
*	OR T78 T81 T82
T84	Device 1171 1190	implanted ICD/CRT-D
T85	Condition 1205 1222	pulmonary disease
T86	Qualifier 1193 1204	Significant
R30	Has_qualifier Arg1:T85 Arg2:T86	
T87	Condition 1231 1260	restrictive pulmonary disease
T88	Condition 1278 1315	chronic obstructive pulmonary disease
T89	Condition 1262 1274;1298 1315	constrictive pulmonary disease
*	OR T88 T89 T87
T90	Scope 1231 1315	restrictive pulmonary disease, constrictive or chronic obstructive pulmonary disease
T91	Scope 1193 1222	Significant pulmonary disease
R31	Subsumes Arg1:T91 Arg2:T90	
T92	Qualifier 1320 1329	any other
T93	Condition 1330 1337;1353 1365	disease of the lungs
T94	Condition 1341 1365	malfunction of the lungs
*	OR T93 T94 T96
T95	Scope 1330 1387	disease or malfunction of the lungs or respiratory system
R32	Has_qualifier Arg1:T95 Arg2:T92	
T96	Condition 1330 1337;1353 1359;1369 1387	disease of the respiratory system
T97	Condition 1402 1418	chronic symptoms
R33	AND Arg1:T95 Arg2:T97	
*	OR T91 T95
T98	Condition 1421 1452	Gastroesophageal Reflux Disease
T99	Condition 1454 1458	GERD
T100	Procedure 1477 1501	significant intervention
T101	Drug 1516 1530	OTC medication
T102	Negation 1502 1505	not
R34	Has_negation Arg1:T101 Arg2:T102	
R35	AND Arg1:T100 Arg2:T101	
R36	Subsumes Arg1:T98 Arg2:T99	
T103	Condition 1545 1563	congenital anomaly
T104	Qualifier 1533 1544	Significant
T105	Condition 1567 1582	medical problem
T106	Non-representable 1533 1662	Significant congenital anomaly or medical problem that in the opinion of the investigator would preclude enrollment in this study
T107	Person 1665 1670	Women
T108	Condition 1679 1687	pregnant
T109	Procedure 1705 1719	pregnancy test
T110	Condition 1723 1737	pre-menopausal
A1	Optional T110
R37	AND Arg1:T110 Arg2:T109	
R38	AND Arg1:T108 Arg2:T110	
T111	Competing_trial 1740 1835	Concurrent enrollment in an investigational study evaluating another device, biologic, or drug.
T112	Condition 1849 1870	intracardiac thrombus
T113	Condition 1872 1878	myxoma
T114	Condition 1880 1885	tumor
T115	Condition 1887 1905	interatrial baffle
T116	Device 1909 1914	patch
T117	Qualifier 1918 1923	other
T118	Condition 1924 1935	abnormality
R39	Has_qualifier Arg1:T118 Arg2:T117	
T119	Procedure 1951 1966	vascular access
T120	Procedure 1971 1999	manipulation of the catheter
T121	Condition 1941 1950	precludes
*	OR T119 T120
T122	Scope 1951 1999	vascular access, or manipulation of the catheter
R40	Has_scope Arg1:T121 Arg2:T122	
R41	AND Arg1:T118 Arg2:T121	
*	OR T112 T113 T114 T115 T116 T118
T123	Observation 2002 2017	Life expectancy
T124	Value 2018 2037	less than 12 months
R42	Has_value Arg1:T123 Arg2:T124	
